JAGLX - Janus Henderson Global Life Sciences T
Nasdaq - Nasdaq Delayed Price. Currency in USD
56.50
-1.32 (-2.28%)
At close: 8:00PM EDT
Stock chart is not supported by your current browser
| Previous Close | 57.82 |
| YTD Return | 12.24% |
| Expense Ratio (net) | 0.92% |
| Category | Health |
| Last Cap Gain | 0.00 |
| Morningstar Rating | ★★★★★ |
| Morningstar Risk Rating | Average |
| Sustainability Rating |
| Net Assets | 3.94B |
| Beta (3Y Monthly) | 1.05 |
| Yield | 0.00% |
| 5y Average Return | N/A |
| Holdings Turnover | 46.00% |
| Last Dividend | 0.00 |
| Average for Category | N/A |
| Inception Date | Dec 31, 1998 |
- Zacks•16 days ago
Is Janus Henderson Global Life Science T (JAGLX) a Strong Mutual Fund Pick Right Now?
Mutual Fund Report for JAGLX
- Zacks•5 months ago
3 Healthcare Funds to Ride VC Funding Wave
U.S. healthcare has caught the fancy of American and foreign venture capitalists alike.
- Zacks•6 months ago
Play a Robust Biotech Industry With These 3 Solid Funds
A burgeoning economy and steady influx of funds make conditions ripe for diversification and further strengthening of the capital base.
